Clinical trial
Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT)…
NCT00430768 · University of Massachusetts, Worcester, Other · Completed
Key facts
| NCT number | NCT00430768 |
|---|---|
| Title | Experimental Gene Transfer Procedure to Treat Alpha 1-Antitrypsin (AAT) Deficiency |
| Official title | Preclinical & Phase I/II Trials of AAV-AAT Vectors: Phase I Trial of Intramuscular Injection of a Recombinant Adeno-Associated Virus Alpha 1-Antitrypsin (rAAV1-CB-hAAT) Gene Vector to AAT-Deficient Adults |
| Acronym | AAT |
| Lead sponsor | University of Massachusetts, Worcester, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH Beacon Therapeutics Industry Alpha-1 Foundation University of Florida National Center for Research Resources (NCRR) |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alpha 1-Antitrypsin Deficiency |
| Intervention type | Biological |
| Interventions | rAAV1-CB-hAAT |
| Enrollment | 9 |
| Start date | Feb 1, 2006 |
| Primary completion | Jan 1, 2015 |
| Completion | Jan 1, 2015 |
| First posted | Feb 2, 2007 |
| Last update posted | Dec 15, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: